StressMarq Biosciences Inc.
Discovery Through Partnership: Excellence Through Quality
Search
All Categories
Antibodies
Kits
Proteins
Small Molecules
Home
Trial Program
eCommerce Login
Shopping Cart
About Us
Ordering
Research Area
Apoptosis
Cell Signaling
Epigenetics
Ion Channels and Transporters
Chaperones
Heat Shock Proteins
Neuroscience
Organelle Markers and Scaffolds
Oxidative Stress
Phosphorylation
Post-translational Modifications
Trafficking
Products
Antibodies
Kits
Proteins
Small Molecules
Distributors
Distributor Tools
What's New
New Products
Promotions
Contact
Support
Protocols
Resources
HSP Resources/ Tools
General Genome/Protein Analysis Tools
Publications Search
Product Search Directories
Patents and Trademarks
General Science
Blog
Home
>
Products
>
Small Molecules
>
SIH-301-50MG
Products
Datasheets
Images
Scientific Background and Publications
Product Name
A-967079
Catalog #
SIH-301-50MG
Size
50mg
Price
$369.00 USD
Add to Cart
Bulk Quote
Alternate Product Sizes
SIH-301-10MG
Type
Inhibitor
Datasheet
SIH 301 A 967079 Ion Channel Inhibitor
Description
TRPA1 blocker
Research Area
Ion Channels
Formula
C12H14FNO
Molecular weight
207.3
Source/Host
Synthetic
Purity
>99%
Solubility
DMSO (25mg/ml)
Appearance
White solid
Safety Phrases
Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 - Do not breathe dust
S24/25 - Avoid contact with skin and eyes
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Hazard Phrases:
H302-H315-H317-H318-H335
Precautionary Phrases:
P261-P280-P305 + P351 + P338
Storage Temp
-20°C
Shipping Temp
Blue Ice or 4°C
Structure of A-967079
Research Background
A-967079 is a TRPA1 antagonist (1) and cell permeable. It has been found to be a potent blocker of TRPA1 channels. It is an oxime analogue and resembles AP18 from a structural perspective, although it has a methyl addition and a chlorine–fluorine substitution. However, compared with AP18 and HC-030031, A-967079 is significantly more potent (100-fold on human and 24-fold on rat TRPA1) and has a much improved pharmacokinetic profile. A-967079 is also more selective, with >1000-fold selectivity over other TRP channels and >150-fold selectivity over 75 other tested proteins (2).
References
1. McGaraughty S., et al. (2010) Mol Pain. 6: 14. jun Chen et al. (2011) PAIN 152: 1165–1173
Order a Print Catalog
Full Name:
*
Company:
*
Phone:
*
Email:
*
Address:
*
Address 2:
City:
*
State/Province:
Please choose one
Alberta
Alaska
Alabama
Arkansas
Arizona
British Columbia
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Manitoba
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana
New Brunswick
North Carolina
North Dakota
Nebraska
New Hampshire
New Jersey
Newfoundland and Labrador
New Mexico
Nova Scotia
Northwest Territories
Nunavut
Nevada
New York
Ohio
Oklahoma
Ontario
Oregon
Pennsylvania
Prince Edward Island
Quebec
Rhode Island
South Carolina
South Dakota
Saskatchewan
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
Yukon
Country:
*
Please choose one
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovinia
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo (Dem. Republic)
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey and Alderney
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Island of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea (Democratic Republic of)
Korea (Republic of)
Kosovo
Kuwait
Kyrgyz Republic
Laos
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua-New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Re union
Republic of Dominica
Romania
Russian Federation
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
USA
Uzbekistan
Vanuatu
Vatican (Holy See)
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
Zip/Postal:
*
Primary Work Interest:
*
Send Print Catalog?
*
Yes
No
Newsletter Sign-Up:
Cellular Stress
Oxidative Stress
Ion Channels & Transporters
Apoptosis
Check box before sending form:
*
Submit